Healthcare professionals

OUR PRODUCTS

Tracleer® (bosentan) is an oral dual endothelin receptor antagonist. Tracleer is the only oral PAH therapy with an established safety and tolerability profile in more than 80,000 patients worldwide.
 


US residents only: www.tracleer.com

 
All others: Learn more
 

DISEASES

Graphical representation of the cardiovascular system

Pulmonary arterial hypertension (PAH) is a serious disease of the arteries connecting the lungs to the heart (the pulmonary arteries).

 
Learn more
 

US Residents

Please note that the information contained in this section of the website is not intended for US residents. Please visit our US webpage.

Please note that the information contained in this section of the website is not intended for US residents. Please visit our US webpage.

Contact

Global Medical Information
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil
Switzerland
Phone:+41 61 565 65 65
Fax:+41 61 565 65 00

Clinical trials

Actelion's clinical trial database

Dedicated to enhancing the transparency

Actelion's clinical trial database

Dedicated to enhancing the transparency